Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience - Pokorny, Thomas; Preller, Katrin H.; Kraehenmann, Rainer; Vollenweider, Franz X. (European neuropsychopharmacology, 2016)
Keywords: 5-HT1A receptor; 5-HT2A receptor; Behavior Rating Scale; Buspirone; Buspirone - pharmacology; Consciousness Disorders - chemically induced; Consciousness Disorders - psychology; Double-Blind Method; Ergotamine; Ergotamine - pharmacology; Female; Hallucinogens - pharmacology; Healthy Volunteers - psychology; Humans; Internal Medicine; Male; Psilocybin; Psilocybin - antagonists & inhibitors; Psilocybin - pharmacology; Psychiatry; Serotonin Receptor Agonists - pharmacology; Visual hallucinations; Young Adult; Ergotamine; 5-HT2A receptor; Buspirone; Psilocybin; Visual hallucinations; 5-HT1A receptor